Although variation in gut microbiome composition has been linked with colorectal cancer (CRC), the factors that mediate the interactions between CRC tumors and the microbiome are poorly understood. MicroRNAs (miRNAs) are known to regulate CRC progression and patient survival outcomes. In addition, recent studies suggested that host miRNAs can also regulate bacterial growth and influence the composition of the gut microbiome. Here, we investigated the association between miRNAs expression in human CRC tumor and normal tissues and the microbiome composition associated with these same tissues.
Introduction
The colon microenvironment hosts trillions of microbes, known as the gut microbiome. A healthy microbiome helps maintain colon microenvironment homeostasis, immune system development, gut epithelial function, and other organ functions [1] [2] [3] [4] [5] . Although many factors impact the composition of the gut microbiome, the overall functional profiles remain stable over time [6, 7] .
Nevertheless, changes in the taxonomic and functional composition of the microbiome have been implicated in many diseases, including colorectal cancer (CRC) [8] [9] [10] [11] . Although the association between microbiome alterations and disease processes has been extensively demonstrated, the directionality, as well as the mediators of the host-microbiome interaction, remain unclear.
Diet has been independently associated with both the gut microbiome and CRC. For example, the western diet (characterized by low fiber and high protein, fat, and sugar) affects gut microbiome composition in humanized mice, whereby mice fed with western diet have increased Firmicutes and decreased Bacteroidetes relative abundance [12, 13] . The same western diet has also long been considered as a risk factor for developing CRC [14] [15] [16] . Using an animal model of CRC, Schulz et al. demonstrated that the high-fat diet (HFD) exacerbates CRC progression; however, treating animals with antibiotics blocks HFD-induced CRC progression [17] . This suggests that diet can drive microbiome composition change in the gut as a precursor to CRC development.
Recent studies have found that host genetic variation can affect microbiome composition. For example, a polymorphism near the LCT gene, which encodes the lactase enzyme, is associated with the abundance of Bifidobacterium in the gut microbiome, and Christensenellaceae family are shown to be heritable, with a higher similarity between monozygotic than dizygotic twins. [18] [19] [20] [21] [22] [23] . This could explain uni-directional host-to-microbiome interaction, especially in CRC, where genetic mutations in host cells are common [24, 25] . Interestingly, in a genetic mutation model of intestinal tumors, germ-free animals developed significantly fewer tumors in the small intestine [26] . Although the finding is limited to the small intestine, the trend shows that CRC development partially depends on the microbiome. In an animal model of colitis-associated CRC, Uronis et al. showed that germ-free mice exhibit normal histology and do not develop tumors, compared to 62% for conventionalized mice that have developed tumors (n=13) [27] .
Additionally, Ridaura et al. demonstrated that when transplanting the microbiome from twins discordant for obesity to germ-free mice, the mice that received the obesity-associated microbiome developed an obese phenotype while the mice that received lean microbiome did not [13] . Clearly, this evidence suggests that host genetics only partially explains hostmicrobiome interaction.
A recent report demonstrated that a fecal microRNAs (miRNAs) can shape the composition of the gut microbiome [28] , indicating a mechanism by which host cells can regulate the microbial community. In CRC, several miRNAs, such as miR-182, miR-503, and miR-17~92 cluster, can regulate multiple genes and pathways and have been found to promote malignant transformation and disease progression [29] [30] [31] . Interestingly, studies have also found that microbiome-derived metabolites can change host gene expression, including expression of miRNAs, in the colon [32, 33] . Taken together, these results suggest a bi-directional interaction between host cells and microbes, potentially mediated through miRNA activity. However, we still know very little about the role of miRNAs in host-microbiome interaction, especially in the context of CRC. With thousands of unique miRNAs and microbial taxa present in the CRC microenvironment, it is challenging to experimentally study all possible pairwise interactions.
Nevertheless, genomic characterization of both miRNA expression and microbial composition in CRC can identify potential interactions between miRNAs and microbes, which can then be used as candidates for functional inspection.
Here, we establish the relationships between miRNAs expression and microbiome composition in CRC patients. We sequenced small RNAs and integrated 16S rRNA gene sequencing data from both tumor and normal colon tissues from 44 patients (88 samples total). We explored the correlation between miRNAs and the microbiome through imputing the miRNA functional pathways and microbiome metabolic pathways in silico ( Supplementary Figure 1) . To our knowledge, this is the first analysis to establish the global relationship between miRNAs expression and microbiome in CRC patients. 16S rRNA sequencing and sequence analysis. The 16S rRNA gene sequencing data were previously published [8] . Raw sequences were deposited at NCBI Sequence Read Archive under project accession PRJNA284355, and processed data files are available in Burns et al. [8] . Briefly, total DNA was extracted from approximately 100 mg of tissue. Tissues were first physically disrupted by placing the tissue in 1 mL of Qiazol lysis solution in a 65 °C ultrasonic water bath for 1-2 h. The efficiency of this approach was verified by observing high abundances of Gram-negative bacteria across all samples, including those from the phylum Firmicutes. DNA was then purified using AllPrep nucleic acid extraction kit (Qiagen, Valencia, CA). The V5-V6 region of the 16S rRNA gene was PCR amplified with multiplexing barcodes [34] . The barcoded amplicons were pooled and ligated to Illumina adaptors. Sequencing was performed on a single lane on an Illumina MiSeq instrument (paired-end). The forward and reverse read pairs were merged using the USEARCH v7 program 'fastq_mergepairs', allowing stagger, with no mismatches, allowed [35] . OTUs were picked using the closedreference picking script in QIIME v1.7.0 using the Greengenes database (August 2013 release) [36] [37] [38] . The similarity threshold was set at 97%, reverse read matching was enabled, and reference based chimera calling was disabled. The unfiltered OTU table used for the analysis is available in Supplementary Table 1 .
Methods
MicroRNA sequencing. To prepare samples for small RNA sequencing, total RNA was extracted using AllPrep nucleic acid extraction kit (Qiagen, Valencia, CA). RNA was quantified using RiboGreen fluorometric assay (Thermo Fisher, Waltham, WA). RNA integrity was then measured using BioAnalyzer 2100 (Agilent, Santa Clara, CA). Library creation and sequencing were performed by the Mayo Clinic Genome Analysis Core. Briefly, small RNA libraries were Figure 1 for an overview of the data analysis steps. Briefly, quality control of miRNA sequencing data was performed using FastQC before and after adaptor trimming with trimmomatic [39] . Then, the paired-end reads were assembled using PANDASeq and aligned to hg38 genome assembly using bowtie2 [40, 41] . Finally, the total mature miRNA counts were generated with HTseq [42] .
MicroRNA sequence data processing and QC. See Supplementary
We removed 7 samples due to low number of total raw reads (fewer than 500,000 raw reads) from the analysis. The remaining 81 samples have between 519,373 and 17,048,093 (median 6,010,361) reads per library, with an average quality score greater than 37 in all libraries. Figure 4) .
Between 283 and 1,000 (median 670) miRNAs had coverage over 1 read, and between 134 and 599 (median 367) miRNAs had coverage over 5 reads ( Figure 1G) . Overall the quality of our sequencing results is on par with previous studies and our previous observations [43] MicroRNA differential expression and correlation analysis. We identified differentially expressed (DE) miRNAs between tumor and normal samples using the DESeq2 package (1.10.1) in R (version 3.2.3) [44] . Raw miRNA counts were filtered to include miRNAs with ≥ 1 read in ≥ 80% of the samples. The remaining 392 miRNAs were then used for DESeq2 analysis.
We define DE miRNAs as showing fold change over 1.5 with false discovery rate (FDR) adjusted p-value (q-value) < 0.05. We performed correlation analysis using Sparse Correlations for Compositional data (SparCC) at the genus level for bacteria [45] . To increase the accuracy of estimation, we performed 20 iterations for each SparCC procedure. We calculated pseudo pvalues using 100 random permutations. Significant correlations were defined as r over 0.05 (or less than -0.05) with a pseudo p-value ≤ 0.05 [8] . Heat maps of the correlation were generated in R using the pheatmap package. We performed hierarchical clustering for both column and rows with average linkage method using Pearson's correlation. We included bacteria with significant correlations with DE miRNAs to perform metagenomic prediction using PICRUSt v1.0.0 [46] . We included miRNAs with significant correlations with CRC associated genera (Fusobacterium, Providencia, Bacteroides, Akkermansia, Roseburia, Porphyromonas, and Peptostreptococcus) to perform pathway enrichment analysis using miRPath v.3 [47, 48] . We generated network visualization of miRNA-microbe using Cytoscape v3.5.1
Results
MicroRNAs differentially expressed in tumor tissues. Before performing differential expression (DE) analysis, we performed extensive quality control of the miRNA data. Our results indicate that miRNA expression is not strongly affected by tumor location, patient gender, patient age, and read coverage, and shows a clear clustering of miRNA data by tumor and normal samples (see Figure 1 and Methods above). To identify small RNAs that are DE between tumor and normal samples, we performed DE analysis using DESeq2 (see Methods).
A total of 76 DE miRNAs were identified, with 55 up-regulated and 21 down-regulated in tumor tissues compared to normal tissues (p-value < 0.05 after FDR correction). A full list of DE miRNAs is available in Supplementary Table 3 . DE miRNAs with higher expression levels in tumor tissues include miR-182, miR-183, miR-503, and miR-17~92 cluster miRNAs (Figure 2 ; Supplementary Table 3 ), all consistent with our previous reports [29, 49] . These miRNAs have all been previously shown to contribute to CRC disease progression; for example, miR-182 and miR-503 were found to cooperatively target FBXW7 and contribute to CRC malignant transformation and progression, and were also predictive of patient survival [29] . The miR-17~92 cluster regulates multiple tumor-suppressive genes in CRC and other cancers [50] . In addition, miR-1, miR-133a, and miR-448 (Supplementary Table 3 ) were observed at higher levels in normal tissues compared with matched tumor tissues, also in agreement with previous reports [49, 51] .
Predicted functions of microbiome taxa correlated with DE miRNAs. To investigate the relationship between individual miRNA and microbiome in CRC tumor samples, we performed correlation analysis using SparCC. SparCC is developed specifically to analyze compositional genomic survey data, such as 16S rRNA gene sequencing and other types of high-throughput sequencing data [45] . Hierarchical clustering revealed several clusters of significantly correlated miRNAs and bacterial taxa ( Supplementary Figure 5) . To further investigate the relationship between miRNAs and microbiome in CRC we selected bacteria significantly correlated with the DE miRNAs ( Figure 3A) . The correlations clearly show a distinct pattern based on the enrichment of miRNAs, even though the correlation analysis is performed only in tumor samples.
We then built a network visualizing the relationship between the top 10 DE miRNAs and their significantly correlated bacteria ( Figure 3B ). The correlation network shows a highlyinterconnected relationship between these miRNAs and bacteria. Interestingly, Blautia, a genus previously found to have lower abundance in tumor samples, is negatively correlated with miR-20a, miR-21, miR-96, miR-182, miR-183, and miR-7974, which are all miRNAs with high expression levels in tumor tissues. Blautia is also positively correlated with the expression level of miR-139, which is a miRNA with high expression levels in normal tissues. Experimental validations are required to investigate the correlations.
We then analyzed the predicted functional composition of the microbiome data and investigated correlations with miRNAs ( Figure 3C ). We hypothesized that if miRNAs selectively affect the growth of certain bacteria, then bacteria correlated with DE miRNAs are likely to represent functional differences between tumor and normal tissues, while the uncorrelated bacteria would not. Using the PICRUSt v.1.0.0 software, we generated the predicted functional profiles of the correlated and uncorrelated bacteria by assigning pathways and enzymes using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. A total of 25 pathways have significantly altered enrichment (two-sided Wilcoxon signed rank test with FDR corrected pvalue < 0.05; Figure 3C ). Interestingly, several metabolic pathways and signaling pathways, including signal transduction, amino acid metabolism, energy metabolism, and linoleic acid metabolism, were all enriched in the uncorrelated group, suggesting increased metabolic processes in this group. For bacteria significantly correlated with DE miRNAs, however, pathways related to transporters, peptidoglycan, and terpenoid backbone biosynthesis have significant enrichment.
Predicted functions of miRNAs correlated with CRC associated bacteria
To investigate the function of miRNAs correlated with CRC-associated bacteria, we focused on bacteria genera previously associated with CRC, including Fusobacterium, Providencia, Bacteroides, Akkermansia, Roseburia, Porphyromonas, and Peptostreptococcus [8, [52] [53] [54] [55] . We hypothesized that if these bacteria affect CRC through modulating miRNA expression, then miRNAs that are significantly correlated with the bacteria are expected to show enrichment in cancer-related genes and pathways. A list of miRNAs significantly correlated with these bacteria is available in Supplementary Table 4 . We separated these miRNAs into groups with positive correlation and negative correlation with each bacteria independently. Then, using the miRPath v.3 software, we predicted the functions of miRNAs by assigning pathways to the miRNA targets using the KEGG database (Supplementary Table 5 ). We visualized the pathways with q-value < 0.01 (modified Fisher's Exact Test; FDR corrected) in Figure 4 .
Our results show that Akkermansia is the only taxon correlates with miRNAs associated with "colorectal cancer" pathway. Fusobacterium, Providencia and Roseburia correlate with miRNAs associated with cancer-related pathways, including "Glioma", "Pancreatic cancer", "Renal cell carcinoma" and "Pathways in cancer". Interestingly, glycan-related pathways, including "mucintype O-glycan biosynthesis", "Other O-Glycan biosynthesis", "Glycosaminoglycan biosynthesis − heparan sulfate/heparin", and "Proteoglycans in cancer", have correlations with all bacteria genera analyzed, except for Akkermansia. This finding corresponds to a previous study showing that Fusobacterium nucleatum infection stimulates mucin secretion in vitro [56] . Additionally, Fusobacterium nucleatum binds to specific Gal-GalNAc, which is expressed by CRC tumors, through the Fap2 protein [57] . Porphyromonas gingivalis were shown to induce a proteoglycan, syndecan-1, shedding in oral epithelial cells [58] . However, the role of the bacteria and glycan interaction is not clear in the context CRC. Cell signaling pathways previously implicated in CRC, such as Ras, PI3K/Akt, ErbB and Hippo pathways are also correlated with these bacteria [59] [60] [61] [62] .
Discussion
Although there is a known association between gut microbiome composition change and CRC [8] [9] [10] [11] , the potential mediators of this relationship remain unclear. One potential mediator is host genetics, and specifically CRC tumor mutational profiles [26, 27] . Additional evidence indicates that miRNAs can mediate host-microbiome interactions in CRC [28] . Here, we presented the first integrated analysis of miRNA expression and gut microbiome profiles in CRC patients. Our data show a highly interconnected correlation network between miRNA expression and the composition of the microbiome and supports the role for miRNAs in mediating host-microbiome interactions.
Active interactions between host and the microbiome in CRC has been previously observed, leading to the proposition that pathogenic "passenger" bacteria colonizing tumor tissue could lead to exacerbated tumor progression [63] . In our analysis, we focused on potential "passenger" bacteria, including Fusobacterium, Providencia, Bacteroides, Akkermansia, Roseburia, Porphyromonas, and Peptostreptococcus. Fusobacterium includes several pathogenic species, and are implicated in dental disease, infections, and CRC [64] [65] [66] . Similarly, Providencia has also been implicated in gastrointestinal infections [8, [67] [68] [69] . The mechanism of Fusobacterium in promoting CRC tumorigenesis and progression has been investigated. It activates the Wnt/βcatenin signaling pathway through FadA protein which binds to the E-cadherin protein on the intestinal epithelial cells (IECs), thus promoting cell proliferation [64] . Several mechanisms could explain this observation. One possibility is that bacteria can infiltrate the intestinal epithelial barrier after certain pathogenic bacteria cleaving the E-cadherin [64, 70] . This could lead to an increased inflammatory response in the colon microenvironment, and the inflammation can lead to DNA damage and contribute to disease progression [63, 64] . Another potential mechanism is that bacteria can directly cause mutations in IECs through virulence proteins. Several of these virulence proteins were found in Escherichia coli and Helicobacter pylori [71, 72] , and results indicate that these virulence factors may be enriched in the CRC microbiome, especially in Fusobacterium and Providencia [8] . However, it is unclear if these bacteria produce virulence proteins that can directly cause DNA damage, and further investigation is required to elucidate this mechanism.
The Wnt/β-catenin pathway activation by Fusobacterium can lead to upregulation of numerous genes related to CRC [73] [74] [75] . One such gene, MYC, is a transcription factor that targets multiple genes related to cell proliferation, cell cycle, and apoptosis. The miR-17~92 cluster is a known target of MYC and has oncogenic properties in several cancer types [31, 50, 76, 77] .
Interestingly, butyrate, a short-chain fatty acid (SCFA) produced by members of the microbiome, diminishes MYC-induced miR-17~92 overexpression in CRC in vitro through its function as histone deacetylase inhibitor [32] . Studies in CRC have consistently found low fecal butyrate levels as well as a reduced relative abundance of butyrate-producing bacteria, such as Firmicutes phylum [32, 52, 78] . One potential explanation is in CRC, the DE miRNAs can affect the growth of certain microbes, which eventually outcompete other species and form a biofilm on tumor tissues [28] . Indeed, our data shows several enriched bacterial nutrient biosynthesis and metabolism pathways in the microbes uncorrelated with DE miRNAs, but not in the correlated group. Interestingly, pathways in bacterial cell motility and secretion are also enriched among uncorrelated bacteria, suggesting that, in addition to promoting bacterial growth, certain miRNAs may be involved in recruiting bacteria to tumor tissues. This may also provide a possible explanation for the observed difference in alpha diversity of tumor microbiomes [8, 79, 80] .
In our analysis of the functions of miRNAs correlated with selected bacteria known to have associations with CRC, the prion diseases, glioma, and morphine addiction pathways found to be enriched in our analysis do not immediately seem related to cancer (Figure 4) . Upon further investigation of miRNAs gene targets in these pathways, we found that several genes included in the pathways may have relevant functions in cancer. For example, Mitogen-activated Protein Kinase (MAPK) is central to cell proliferation and survival; Interleukin-6 (IL6) and Interleukinbeta (IL1β) are cytokines involved in inflammation; Protein Kinase A (PKA) is important in regulating nutrient metabolism; Bcl-2-associated X protein (BAX) is a tumor suppressor gene;
and Prion protein (PRNP) are known to have a significant role in regulating immune cell function [81] [82] [83] .
A recent study has suggested an additional mechanism affecting host-microbiome interactions that may promote CRC tumorigenesis and progression [57, 84] . Abed et al. showed that Fap2 produced by Fusobacterium binds to glycan produced by CRC to attach to the tumor tissue [57] .
Interestingly, glycan biosynthesis pathways were enriched in targets of the miRNAs correlated with CRC-associated bacteria. The increased glycan production may increase recruitment of certain bacteria, such as Fusobacterium, to the tumor location. This result highlights a novel potential mechanism for miRNAs, through regulating glycan biosynthesis, to attract specific microbes to the tumor microenvironment, and thus impact tumor development. Interestingly, mucin-type O-glycan biosynthesis pathway is enriched in miRNAs positively correlated with Fusobacterium but negatively correlated with Bacteroides and Porphyromonas. This suggests that these bacteria may have different mechanisms of attachment to the mucosal surface due to different ability to bind to O-glycan [85] . Additional studies are required to test the association between Fusobacterium, tumorigenesis, and miRNA-driven glycan production.
It is important to note that our study uses 16S rRNA gene sequencing to characterize microbiome taxonomic composition and computationally predicted pathway composition using PICRUSt v1.0.0 [46] . Although this method is widely used, metagenomics shotgun sequencing can be more accurate and informative in understanding the functional makeup of a microbial community. Similarly, to impute miRNA functional profiles, we used an in silico prediction method, miRPath [46, 47] . While these two methods have both been rigorously tested and validated with experimental data, the results remain predictions and may not represent the real biological system [46, 47] . Another limitation of our approach is that it identifies correlations and not causal relationships. Nevertheless, this approach allows us to generate a microbiome-and miRNA transcriptome-wide characterization of potential interactions, which shed light on potential new mechanisms of host-microbiome interactions. In addition, we highlight candidates for potentially interacting host miRNAs and microbial taxa, which can be validated in model organism studies that will address causality.
Conclusions
Our analysis, together with evidence from previous studies, suggests that miRNAs likely mediate host-microbiome interaction in CRC. We identify potential novel mechanisms that mediate this interaction and may have a role in CRC tumorigenesis, including a possible role for miRNA-driven glycan production in the recruitment of pathogenic microbial taxa. The interactions identified here could be a direct target for developing therapeutic strategies that can benefit CRC patients. Follow-up studies in model organisms are warranted to assess the causal role of individual microbes and miRNAs in CRC. 
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